PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)

CUSIP: 71715X203

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+135,934
Put/Call ratio
876%
SEC-reported price per share
$2.91
Number of holders
27
Value change
+$391,731
Number of buys
12
Open additional details 1 more signal available
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,666,413

Security key

71715X203

Report period

Q1 2023

Institutions

27

Top holders

10

Ownership snapshot

Top reported holders of PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Ayrton Capital LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F Lead comparable stake: 9.7% Showing 1-6 of 15 holder rows.

Quick read

Ayrton Capital LLC leads the comparable SEC ownership view at 9.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership Top 5
Ayrton Capital LLC 9.7%
K2 PRINCIPAL FUND, L.P. 6.9%
VANGUARD GROUP INC 6.1%
EQUITEC PROPRIETARY MARKETS, LLC 3.1%
GEODE CAPITAL MANAGEMENT, LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ayrton Capital LLC
13F
Company
13F
9.7%
$3,027,071
1,033,130 shares
31 Dec 2022
K2 PRINCIPAL FUND, L.P.
13F
Company
13F
6.9%
$2,145,068
732,105 shares
31 Dec 2022
VANGUARD GROUP INC
13F
Company
13F
6.1%
$1,917,735
654,517 shares
31 Dec 2022
EQUITEC PROPRIETARY MARKETS, LLC
13F
Company
13F
3.1%
$968,933
330,694 shares
31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
1.6%
$511,000
175,264 shares
31 Dec 2022
SABBY MANAGEMENT, LLC
13F
Company
13F
0.92%
$287,076
97,978 shares
31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
27
Shares
3,527,753
Rows available
27
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
27
Q1 2023 holders
27
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .